Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis.

scientific article

Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JCB.26433
P698PubMed publication ID29058760

P50authorYusuf AkhterQ41116216
Abdur RubQ57080365
Shams TabrezQ38323793
P2093author name stringNaidu Subbarao
Atahar Husein
Mohammad Kashif
Mohd Arish
Ponnusamy Kalaiarasan
Partha P Manna
P2860cites workOrchestration of membrane receptor signaling by membrane lipidsQ38427974
New Approaches on Leishmaniasis Treatment and Prevention: A Review of Recent PatentsQ38590703
Sphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseasesQ38604586
UDP-galactopyranose mutase, a potential drug target against human pathogenic nematode Brugia malayiQ39254459
Leishmania-induced biphasic ceramide generation in macrophages is crucial for uptake and survival of the parasite.Q39361848
Galactofuranose-containing glycoconjugates in trypanosomatids.Q40946525
A novel screening method for cell wall mutants in Aspergillus niger identifies UDP-galactopyranose mutase as an important protein in fungal cell wall biosynthesisQ42053815
Biosynthesis of galactofuranose in kinetoplastids: novel therapeutic targets for treating leishmaniasis and chagas' diseaseQ42752718
Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function.Q46130895
Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth.Q46618665
PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small moleculesQ48785859
An improved united atom force field for simulation of mixed lipid bilayers.Q51798189
Docking and molecular dynamics simulation study of EGFR1 with EGF-like peptides to understand molecular interactions.Q54200419
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceQ24286950
Gapped BLAST and PSI-BLAST: a new generation of protein database search programsQ24545170
PDBsum new thingsQ24655887
Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acidQ24682763
Targeting UDP-galactopyranose mutases from eukaryotic human pathogensQ26862107
UDP-galactopyranose mutase has a novel structure and mechanismQ27635026
Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutaseQ27664551
Crystal Structures of Trypanosoma cruzi UDP-Galactopyranose Mutase Implicate Flexibility of the Histidine Loop in Enzyme ActivationQ27679366
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMRQ27860778
Comparative protein modelling by satisfaction of spatial restraintsQ27860866
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactionsQ27861128
Development and validation of a genetic algorithm for flexible dockingQ28236574
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracyQ28251042
Virtual screening, identification and in vitro testing of novel inhibitors of O-acetyl-L-serine sulfhydrylase of Entamoeba histolyticaQ28480744
Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' diseaseQ28481596
Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics studyQ28542531
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?Q29038941
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitQ29615867
Deciphering key features in protein structures with the new ENDscript serverQ29617219
Molecular modeling on pyruvate phosphate dikinase of Entamoeba histolytica and in silico virtual screening for novel inhibitors.Q30363533
Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogensQ33856548
Cell biology of Leishmania spp.: invading and evading.Q34115514
Leishmanicidal activities of Artemisia annua leaf essential oil against Visceral LeishmaniasisQ34569670
Galactofuranose metabolism: a potential target for antimicrobial chemotherapyQ35100244
The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hostsQ35234866
Contribution of galactofuranose to the virulence of the opportunistic pathogen Aspergillus fumigatusQ36846175
An insight on targets and patented drugs for chemotherapy of Chagas disease.Q37067251
The LPG1 gene family of Leishmania majorQ37218050
Mucocutaneous leishmaniasis: an imported infection among travellers to central and South AmericaQ37561902
P433issue3
P304page(s)2653-2665
P577publication date2017-11-10
P1433published inJournal of Cellular BiochemistryQ6294917
P1476titleIdentification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis
P478volume119

Search more.